Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.

Authors :: Kamperman, R.G.
Leeuwen, E.M. van
Willems, M.
Kooi, A.J. van der
Gelderman, K.A.
Hamann, D.
Lochem, E.G. van
Meek, B.
Molen, R.G. van der
Platteel, A.C.
Otten, H.G.
Schreurs, M.W.
Raaphorst, J.
Kamperman, R.G.
Leeuwen, E.M. van
Willems, M.
Kooi, A.J. van der
Gelderman, K.A.
Hamann, D.
Lochem, E.G. van
Meek, B.
Molen, R.G. van der
Platteel, A.C.
Otten, H.G.
Schreurs, M.W.
Raaphorst, J.
Source :: Journal of Autoimmunity; 103081; 0896-8411; 139; 103081; ~Journal of Autoimmunity~103081~~~~0896-8411~~139~~103081
Publication Year :: 2023
Abstract: 01 september 2023<br />Contains fulltext : 295946.pdf (Publisher’s version ) (Closed access)

Database :: OAIster
Journal :: Journal of Autoimmunity; 103081; 0896-8411; 139; 103081; ~Journal of Autoimmunity~103081~~~~0896-8411~~139~~103081
Publication Type :: Electronic Resource
Accession number :: edsoai.on1399414425
Document Type :: Electronic Resource

Tools